The Acquisition Deal

Oura announced that it is acquiring AI-native primary care company Counsel Health for $625 million. The transaction follows Oura's previous postponement of its planned IPO, citing market uncertainty.

Counsel Health operates an AI-driven healthcare platform that pairs a chat-based medical assistant with access to licensed physicians. Its capabilities were integrated into the Oura application earlier in the year.

Users can interact with the medical AI for personalized health guidance and communicate directly with physicians inside the Oura ecosystem. The companies plan to scale this integration across preventative, acute, specialty, and chronic care services.

Expanding Health Offerings

As competition in the smart ring market intensifies with rivals like RingConn and Ultrahuman, Oura is scaling its software and medical services offerings to maintain its market position.

Oura CEO Tom Hale stated that the integration enables members to turn physiological data into direct clinical actions, ranging from general health queries and prescriptions to lab results and physician referrals.

Counsel Health previously secured a $25 million Series A funding round backed by investors including Andreessen Horowitz and GV, with total reported venture funding reaching approximately $36 million.

Leadership and Integration

Following the completion of the acquisition, Counsel will maintain its services for enterprise partners with the objective of scaling its AI care model beyond the Oura membership base.

Counsel CEO Muthu Alagappan will transition to Oura as chief clinical AI officer alongside the startup's approximately 70 employees.

Alagappan noted that the platform was designed around clinical safety, maintaining physician oversight for medical decisions while utilizing objective biometric metrics provided by Oura wearables to inform care.

Financial Context

The transaction is anticipated to finalize prior to the end of 2027.

Oura also reported significant financial growth, noting quarterly revenue reaching $533 million and fiscal year revenue hitting approximately $1.75 billion.

The company previously secured an $11 billion valuation following a late-stage funding round.